Increased chloride efflux in colchicine-resistant airway epithelial cell lines

Biochemical Pharmacology

Volumn 68, Issue 2, 2004, Pages 253-261

  Dragomir, Anca ^a   Roomans, Godfried M ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

3 isobutyl 1 methylxanthine; Calu 3; CF; CFBE; CFSME; CFTR; cystic fibrosis; cystic fibrosis bronchial epithelial cells; cystic fibrosis submucosal epithelial cells; cystic fibrosis transmembrane conductance regulator; IBMX; normal submucosal epithelial cells

Indexed keywords

CHLORIDE; CHLORIDE CHANNEL; COLCHICINE; CYCLIC AMP; MULTIDRUG RESISTANCE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL CLONE; CELL LINE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM;

BIOLOGICAL TRANSPORT; BRONCHI; CHLORIDES; COLCHICINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOSKELETON; DRUG RESISTANCE, MULTIPLE; EPITHELIAL CELLS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 2942576143     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.03.037     Document Type: Article

References (38)

1. http://www.genet.sickkids.on.ca/cftr.
2. Ben-Chetrit E., Levy M. Colchicine: 1998 update. Semin. Arthritis Rheum. 28:1998;48-59
3. Sermet-Gaudelus I., Stoven V., Annereau J.P., Witko-Sarsat V., Reinert P., Guyot M. Interest of colchicine for the treatment of cystic fibrosis patients. Prelim. Rep. Mediat. Inflamm. 8:1999;13-15
4. Willemot J.M., Sermet-Gaudelus I., Lenoir G. New therapeutic approaches to cystic fibrosis. Ann. Pharm. Fr. 61:2003;253-258
5. Roepe P.D. The role of the MDR protein in altered drug translocation across tumor cell membranes. Biochim. Biophys. Acta. 1241:1995;385-405
6. Roepe P.D., Wei L.Y., Hoffman M.M., Fritz F. Altered drug translocation mediated by the MDR protein: direct, indirect, or both? J. Bioenerg. Biomembr. 28:1996;541-555
7. Golstein P.E., Boom A., van Geffel J., Jacobs P., Masereel B., Beauwens R. P-glycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch. 437:1999;652-660
8. Lallemand J.Y., Stoven V., Annereau J.P., Boucher J., Blanquet S., Barthe J., et al. Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis? Lancet. 350:1997;711-712
9. Hoffman M.M., Roepe P.D. Analysis of ion transport perturbations caused by hu MDR1 protein overexpression. Biochemistry. 36:1997;11153-11168
10. Wei L.Y., Hoffman M.M., Roepe P.D. Altered pHi regulation in 3T3/CFTR clones and their chemotherapeutic drug-selected derivatives. Am. J. Physiol. 272:1997;C1642-C1653
11. Gerard V., Rouzaire-Dubois B., Dilda P., Dubois J.M. Alterations of ionic membrane permeabilities in multidrug-resistant neuroblastoma × glioma hybrid cells. J. Exp. Biol. 201:1998;21-31
12. Howard E.M., Roepe P.D. Purified human MDR 1 modulates membrane potential in reconstituted proteoliposomes. Biochemistry. 42:2003;3544-3555
13. Rychlik B., Pulaski L., Sokal A., Soszynski M., Bartosz G. Transport of organic anions by multidrug resistance-associated protein in the erythrocyte. Acta Biochim. Pol. 47:2000;763-772
14. Krapf R., Berry C.A., Verkman A.S. Estimation of intracellular chloride activity in isolated perfused rabbit proximal convoluted tubules using a fluorescent indicator. Biophys. J. 53:1988;955-962
15. Chen P.Y., Illsley N.P., Verkman A.S. Renal brush-border chloride transport mechanisms characterized using a fluorescent indicator. Am. J. Physiol. 254:1988;F114-F120
16. Schinkel A.H., Roelofs E.M., Borst P. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res. 51:1991;2628-2635
17. Putterman C., Ben-Chetrit E., Caraco Y., Levy M. Colchicine intoxication: clinical pharmacology, risk factors, features, and management. Semin. Arthritis Rheum. 21:1991;143-155
18. Taylor E.W. The mechanism of colchicine inhibition of mitosis. J. Cell Biol. 25:1965;145-160
19. Deery W.J., Weisenberg R.C. Kinetic and steady-state analysis of microtubules in the presence of colchicine. Biochemistry. 20:1981;2316-2324
20. Wioland M.A., Fleury-Feith J., Corlieu P., Commo F., Monceaux G., Lacau-St-Guily J. CFTR, MDR1 and MRP1 immunolocalization in normal human nasal respiratory mucosa. J. Histochem. Cytochem. 48:2000;1215-1222
21. Johannesson M., Sandberg Nordqvist A.C., Bogdanovic N., Hjelte L., Schalling M. Polymorphic expression of multidrug resistance mRNA in lung parenchyma of nonpregnant and pregnant rats: a comparison to cystic fibrosis mRNA expression. Biochem. Biophys. Res. Commun. 239:1997;606-611
22. Hurbain I., Sermet-Gaudelus I., Valle B., Feuillet M.N., Lenoir G., Bernaudin J.F., et al. Evaluation of MRP1-5 gene expression cystic fibrosis patients homozygous for the ΔF508 mutation. Pediatr. Res. 54:2003;627-634
23. Ito S. Is CFTR dysfunction in cystic fibrosis compensated by MRPs? Pediatr. Res. 54:2003;625-626
24. Trezise A.E., Romano P.R., Gill D.R., Hyde S.C., Sepulveda F.V., Buchwald M., et al. The multidrug resistance and cystic fibrosis gene have complementary patterns of expression. EMBO J. 11:1992;4291-4303
25. Breuer W., Slotki I.N., Ausiello D.A., Cabantchik I.Z. Induction of multidrug resistance downregulates the expression of CFTR in colon epithelial cells. Am. J. Physiol. 265:1993;C1711-C1715
26. Cao L., Owsianik G., Jaspers M., Janssens A., Cuppens H., Cassiman J.J. Functional analysis of CFTR chloride channel activity in cells with elevated MDR1 expression. Biochem. Biophys. Res. Commun. 304:2003;248-252
27. Wei L.Y., Stutts M.J., Hoffman M.M., Roepe P.D. Overexpression of the cystic fibrosis transmembrane conductance regulator in NIH 3T3 cells lowers membrane potential and intracellular pH and confers a multidrug resistance phenotype. Biophys. J. 69:1995;883-895
28. Fritz F., Howard H.M., Hoffman M.M., Roepe P.D. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR1 protein. Biochemistry. 38:1999;4214-4226
29. Hardy S.P., Goodfellow H.R., Valverde M.A., Gill D.R., Sepulveda V., Higgins C.F. Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J. 14:1995;68-75
30. Hoffman M.M., Wei L.Y., Roepe P.D. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J. Gen. Physiol. 108:1996;295-313
31. Luker G., Flagg T.P., Sha Q., Luker K.E., Pica C.M., Nichols C.G., et al. MDR1 P-glycoprotein reduces influxes of substrates without affecting membrane potential. J. Biol. Chem. 276:2001;49053-49060
32. Bond T.D., Higgins C.F., Valverde M.A. P-glycoprotein and swelling activated chloride channels. Methods Enzymol. 292:1998;359-370
33. Idriss H.T., Hannun Y.A., Boulpaep E., Basavappa S. Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say! J. Physiol. 5243:2000;629-636
34. Hainsworth A.H., Henderson R.M., Hickman M.E., Hladky S.B., Rowlands T., Twentyman P.R., et al. Hypotonicity-induced anion fluxes in cells expressing the multidrug-resistance-associated protein, MRP. Pflugers Arch. 432:1996;234-240
35. Darby M., Kuzmiski J.B., Panenka W., Feighan D., MacVicar B.A. ATP released from astrocytes during swelling activates chloride channels. J. Neurophysiol. 89:2003;1870-1877
36. Roomans G.M. Pharmacological treatment of the ion transport defect in cystic fibrosis. Exp. Opin. Invest. Drugs. 10:2001;1-19
37. Roomans G.M. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis. Am. J. Respir. Med. 2:2003;513-531
38. Maitra R., Shaw C.M., Stanton B.A., Hamilton J.W. Increased functional cell surface expression of CFTR and ΔF508-CFTR by the anthracycline doxorubicin. Am. J. Physiol. 280:2001;C1031-C1037